Altria's 'Reduced Risk' Innovation To Offset Secular Pressures

The FDA has begun the scientific review of Philip Morris International's Modified Risk Tobacco Product Application for its iQOS device. If and when iQOS gets approved, Altria will get exclusive rights to sell the products in the U.S.